{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:38:11Z","timestamp":1786718291736,"version":"build-2736575974"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Ophthalmol"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/ijo.ijo_708_18","type":"journal-article","created":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T00:32:27Z","timestamp":1559176347000},"page":"884","source":"Crossref","is-referenced-by-count":27,"title":["Intravitreal aflibercept injection in Indian eyes with retinopathy of prematurity"],"prefix":"10.4103","volume":"67","author":[{"given":"Vasumathy","family":"Vedantham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0301-4738.259052-1","first-page":"387","volume-title":"Antivascular endothelial growth factor in the treatment of retinopathy of prematurity","author":"Patel","year":"2016","journal-title":"Curr Opin Ophthalmol"},{"key":"key-10.4103\/0301-4738.259052-2","first-page":"603","volume-title":"Efficacy of intravitreal bevacizumab for stage 3+retinopathy of prematurity","author":"Mintz-Hittner","year":"2011","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0301-4738.259052-3","first-page":"1008","volume-title":"Outcomes after intravitreal bevacizumab versus laser photocoagulation for retinopathy of prematurity: A 5-year retrospective analysis","author":"Hwang","year":"2015","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.259052-4","first-page":"2027","volume-title":"Intravitreal ranibizumab as a primary or a combined treatment for severe retinopathy of prematurity","author":"Ar\u00e1mbulo","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"key-10.4103\/0301-4738.259052-5","first-page":"15","volume-title":"Structural, visual and refractive outcomes of intravitreal aflibercept injection in high-risk prethreshold type 1 retinopathy of prematurity","author":"Salman","year":"2015","journal-title":"Ophthalmic Res"},{"key":"key-10.4103\/0301-4738.259052-6","first-page":"711","volume-title":"Aflibercept in wet AMD: Specific role and optimal use","author":"Semeraro","year":"2013","journal-title":"Drug Des Devel Ther"},{"key":"key-10.4103\/0301-4738.259052-7","first-page":"e5","volume-title":"What are the half-lives of ranibizumab and aflibercept (VEGF Trap-eye) in human eyes.Calculations with a mathematical model?","author":"Stewart","year":"2011","journal-title":"Eye Reports"},{"key":"key-10.4103\/0301-4738.259052-8","unstructured":"EYLEA\u2122 (aflibercept) injection: US prescribing information. Tarrytown, NY, USA; Regeneron Pharmaceuticals, Inc. Available from: http:\/\/www.regeneron.com\/Eylea\/eylea-fpi.pdf. [Last accessed on 2012 Apr 02]."},{"key":"key-10.4103\/0301-4738.259052-9","first-page":"479","volume-title":"Changes in systemic vascular endothelial growth factor levels after intravitreal injection of aflibercept in infants with retinopathy of prematurity","author":"Huang","year":"39;s","journal-title":"Graefe"}],"updated-by":[{"DOI":"10.4103\/0301-4738.265131","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000}}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:33:24Z","timestamp":1786714404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_708_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":9,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"alternative-id":["259052"],"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_708_18","relation":{},"ISSN":["0301-4738"],"issn-type":[{"value":"0301-4738","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}